Loading...
XNASISRG
Market cap186bUSD
Dec 20, Last price  
524.43USD
1D
0.10%
1Q
7.86%
Jan 2017
644.29%
Name

Intuitive Surgical Inc

Chart & Performance

D1W1MN
XNAS:ISRG chart
P/E
103.89
P/S
26.22
EPS
5.05
Div Yield, %
0.00%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
13.85%
Revenues
7.12b
+14.49%
138,803,000227,338,000372,682,000600,828,000874,919,0001,052,168,0001,413,000,0001,757,300,0002,178,800,0002,265,100,0002,131,700,0002,384,400,0002,704,400,0003,128,900,0003,724,200,0004,478,500,0004,358,400,0005,710,100,0006,222,200,0007,124,100,000
Net income
1.80b
+35.98%
23,478,00094,134,00072,044,000144,537,000204,315,000232,606,000381,800,000495,100,000656,600,000671,000,000418,800,000588,800,000735,900,000660,000,0001,127,900,0001,379,300,0001,060,600,0001,704,600,0001,322,300,0001,798,000,000
CFO
1.81b
+21.67%
30,315,00070,787,00099,845,000205,687,000278,235,000385,055,000528,000,000677,600,000814,200,000880,000,000665,100,000771,900,0001,042,900,0001,143,900,0001,169,600,0001,598,200,0001,484,800,0002,089,400,0001,490,800,0001,813,800,000
Earnings
Jan 21, 2025

Profile

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
IPO date
Jun 13, 2000
Employees
12,120
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
7,124,100
14.49%
6,222,200
8.97%
5,710,100
31.01%
Cost of revenue
3,393,400
2,905,200
2,422,600
Unusual Expense (Income)
NOPBT
3,730,700
3,317,000
3,287,500
NOPBT Margin
52.37%
53.31%
57.57%
Operating Taxes
141,600
262,400
162,200
Tax Rate
3.80%
7.91%
4.93%
NOPAT
3,589,100
3,054,600
3,125,300
Net income
1,798,000
35.98%
1,322,300
-22.43%
1,704,600
60.72%
Dividends
Dividend yield
Proceeds from repurchase of equity
(120,000)
(2,373,600)
64,900
BB yield
0.10%
2.47%
-0.05%
Debt
Debt current
24,200
20,400
Long-term debt
129,000
139,200
174,000
Deferred revenue
45,600
41,000
36,800
Other long-term liabilities
275,400
398,300
(123,800)
Net debt
(7,214,200)
(9,201,700)
(12,840,600)
Cash flow
Cash from operating activities
1,813,800
1,490,800
2,089,400
CAPEX
(1,064,200)
(532,400)
(353,500)
Cash from investing activities
(360,100)
1,370,800
(2,461,500)
Cash from financing activities
(287,600)
(2,572,300)
43,000
FCF
1,470,600
2,452,200
2,895,000
Balance
Cash
5,223,200
6,741,500
8,619,500
Long term investments
2,120,000
2,623,600
4,415,500
Excess cash
6,986,995
9,053,990
12,749,495
Stockholders' equity
4,820,900
3,408,700
4,787,500
Invested Capital
8,961,900
7,701,600
7,130,300
ROIC
43.08%
41.19%
46.41%
ROCE
27.07%
30.04%
27.58%
EV
Common stock shares outstanding
357,400
362,000
365,800
Price
337.36
27.14%
265.35
-26.15%
359.30
31.76%
Market cap
120,572,464
25.52%
96,056,700
-26.92%
131,431,940
33.55%
EV
113,447,964
86,925,700
118,641,740
EBITDA
4,152,500
3,682,800
3,597,700
EV/EBITDA
27.32
23.60
32.98
Interest
29,700
Interest/NOPBT
0.90%